Mechanistically, NLRP3 was shown to interact directly with the TGF-β receptor, promoting mothers against decapentaplegic homolog 3 (SMAD3) phosphorylation and facilitating Th17-to-Treg trans-differentiation within the tumor microenvironment. The gene discussed is NLRP3; the disease is neoplasm.